DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Bennouna J. et al.
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Lancet Oncol 2013;
14: 29-37
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.